Obstetrics & Gynecology Doctors in Port Angeles, WA Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Oksana Y Shklyanka, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St # 3e, Port Angeles, WA 98362 Phone: 360-565-0999    Fax: 360-452-7303

Alford Nathaniel Vassall Jr., M.D. Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St Ste A, Port Angeles, WA 98362 Phone: 360-655-0999    Fax: 360-452-7303

Mr. Stephen D Bush, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 939 Caroline St # 3e, Port Angeles, WA 98362 Phone: 360-565-0999    Fax: 360-452-7303

Sheena Plamoottil, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 907 Georgiana St, Port Angeles, WA 98362 Phone: 360-565-0999    Fax: 360-452-7303

Dr. Gretchen A Heinrichs, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 433 E 8th St, Port Angeles, WA 98362 Phone: 360-565-0999    Fax: 360-452-7303

Dr. Quang T Nguyen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 433 E 8th St, Port Angeles, WA 98362 Phone: 360-565-0999    Fax: 360-452-7303

News Archive

New computational modeling technology to noninvasively assess likelihood of heart attack

The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.

Medi-551 antibody treatment decreases number of cancer stem cells by half in multiple myeloma patients

An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to results of a preliminary clinical trial led by Johns Hopkins Kimmel Cancer Center scientists.

Women with gestational glucose intolerance at risk of metabolic syndrome

Women who have gestational glucose intolerance (a condition less severe than gestational diabetes) exhibit multiple cardiovascular risk factors as early as three months after birth, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.

Read more Medical News

› Verified 2 days ago